• Explore /
  • Poster
  • / NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Abstract Poster

Authors

null

Matthew Ingham

Columbia University Irving Medical Center, New York, NY

Matthew Ingham , Jacob B Allred , Katherine Gano , Suzanne George , Steven Attia , Melissa Amber Burgess , Sosipatros Alexandros Boikos , Nam Bui , James Lin Chen , Julia Lee Close , Mahesh Seetharam , Premal H. Thaker , Gary K. Schwartz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03880019.

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS11570)

DOI

10.1200/JCO.2020.38.15_suppl.TPS11570

Abstract #

TPS11570

Poster Bd #

458

Abstract Disclosures

Similar Posters

First Author: Kristine Peregrino Lacuna

First Author: Elias Chandran

First Author: Patrick Glen Pilié

First Author: Olga Vornicova